Effects of the 5-Ht2a Antagonist Sarpogrelate on Walking Ability in Patients With Intermittent Claudication as Measured Using the Walking Impairment Questionnaire
Annals of Vascular Diseases
doi 10.3400/avd.avdoa08009
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2008
Authors
Publisher
The Editorial Committee of Annals of Vascular Diseases